Trial Outcomes & Findings for Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II) (NCT NCT01945112)

NCT ID: NCT01945112

Last Updated: 2018-12-12

Results Overview

Blister data were collected without regard to whether the foot was right or left.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

128 participants

Primary outcome timeframe

within 7 days of application of tape

Results posted on

2018-12-12

Participant Flow

Unit of analysis: number of sites where tape was applied

Participant milestones

Participant milestones
Measure
Paper Tape on Right and No Tape on Left Foot
Paper tape was applied to study participants' blister prone areas or a randomly selected spot (if no blister history on that foot) - with untaped areas of the same foot as control.
Paper Tape on Left and No Tape on Right Foot
Paper tape was applied to study participants' blister prone areas or a randomly selected spot (if no blister history on that foot) - with untaped areas of the same foot as control.
Overall Study
STARTED
77 153
51 87
Overall Study
COMPLETED
77 153
51 87
Overall Study
NOT COMPLETED
0 0
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Paper Tape
n=128 Participants
Paper was applied to study participants' blister prone areas or a randomly selected spot (if no blister history on that foot) - with untaped areas of the same foot as control.
Age, Continuous
39.3 years
n=5 Participants
Sex: Female, Male
Female
31 Participants
n=5 Participants
Sex: Female, Male
Male
97 Participants
n=5 Participants

PRIMARY outcome

Timeframe: within 7 days of application of tape

Blister data were collected without regard to whether the foot was right or left.

Outcome measures

Outcome measures
Measure
Paper Tape
n=128 Participants
Paper tape was applied to study participants' blister prone areas or a randomly selected spot (if no blister history on that foot) - with untaped areas of the same foot as control.
Count of Participants With Any Foot Blister in Taped or Untaped Area of the Foot
Blister anywhere
106 Participants
Count of Participants With Any Foot Blister in Taped or Untaped Area of the Foot
Blister in taped area
30 Participants
Count of Participants With Any Foot Blister in Taped or Untaped Area of the Foot
Blister in untaped area
81 Participants

Adverse Events

Paper Tape on RIght Foot and No Tape on Left Foot

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Tape on Left Foot and No Tape on Right Foot

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Grant Lipman

Stanford Department of Emergency Medicine

Phone: 415-290-9286

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place